Big Pharma Bets Big on China




China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere.




China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
4503.TOAstellas PharmaAstraZenecaAZN.LNBayerBAYN.XEBetsBigBiopharmaceuticalsBiotechnology Servicesbusiness newsC&E Industry News FilterchinaCommunityContent TypesContractsContracts/OrderscorporateCorporate/Industrial NewsDemographicsEconomyFactiva Filtersgeneral newsgovernment policyHealthhealthcareHealthcare/Life Sciencesindustrial newsJNJJohnson & JohnsonJP:4503LatestLicensing Agreementslife sciencesmedical treatmentsMedical Treatments/ProceduresMedicationsMerckModernaMRKMRNAnon-government contractsNon-Government Contracts/OrdersOrdersPascal SoriotPFEPfizerPharmaPharmaceuticalspoliticalPolitical/General NewsproceduresregulationRegulation/Government PolicysocietySociety/Communityspecialized drugsSpecialized Drugs/MedicationsSYNDUK:AZNVaccinesWSJ-PRO-WSJ.comwsjcorpXE:BAYN
Comments (0)
Add Comment